Methodological Challenges in Estimation of the Life Time Prevalence of Alcohol Consumption in Iran: Current Practice and Guidelines for Futures Studies

Document Type: Review Article

Authors

1 Regional Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

2 Research Center for Social Determinants of Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

3 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

4 Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

5 Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

6 Shahid-Bahonar University, Kerman, Iran

Abstract

Background: The prevalence of alcohol consumption in Iran cannot be estimated because large variations have been observed in the reported prevalences of alcohol consumption. The main aim of this study was to assess the methodological challenges in estimation of the life time prevalence of alcohol consumed in Iran. By the same token we provided a standard approach for future researches in this regard.
Methods: Published articles were reviewed systematically. Using the risk of bias tool, 49 out of 600 articles met the eligibility criteria. Based on the population of alcohol consumers, the included studies were categorized into 5 groups: general populations, patients, school students, university students, and specific population (first relatives of opium addicts and women who were faced with epistemic violence).
Results: There was a paucity of reliable information in about 40% of provinces. Almost all studies applied the direct size estimation methods, but 11 studies used face to face interview and 38 studies used self-administered questionnaires. The non-response bias seemed prominent in entire studies except those on school students. It is important to mention that 97% of papers in general population did not represent any information about the non-response rate. The reported prevalence ranged from 1.37% in university students to 88.8% in patient population. Even among university students, the prevalence varied considerably (1.37% to 34.7%).
Conclusion: The observed huge variations in the reported prevalence of alcohol consumption, due to the methodological consideration, appear largely in Iran. Therefore, it is necessary to develop a standard protocol for data collection and sampling to harmonize the findings in future studies. In addition, it is recommended to assess the frequency of alcohol use by indirect methods such as the Network Scale Up method.

 
 

Keywords


  1. Singh Z. Alcohol or health: choice is yours. The Health Agenda 2014; 2(4):108-11.
  2. Gulland A. Alcohol consumption kills 3.3 million people a year, WHO calculates. BMJ 2014; 348:g3335.
  3. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol as a risk factor for global burden of disease. Eur Addict Res 2003; 9(4):157-64.
  4. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373(9682):2223-33.
  5. Hamidieh M, Matlabi N, Aasheri H, Boroujerdi A. Assessment of prevalence of  Stimulants, Alcohol, Ecstasy Among Youths 15-35 Years Old in Tehran. Pejouhesh. 2008;315-319.
  6. Van Gelder MM, Bretveld RW, Roeleveld N. Web-based questionnaires: the future in epidemiology? Am J Epidemiol 2010; 172(11):1292-8.
  7. Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health 1998; 1(2):37-40.
  8. Farhadinasab A, Allahverdipour H, Bashirian S, Mahjoub H. Lifetime pattern of substance abuse, parental support, religiosity, and locus of control in adolescent and young male users. Iranian Journal of Public Health 2008; 37(4):88-95.
  9. Allahverdipour H, Hidarnia A, Kazemnegad A, Shafii F, Azad Fallah P, Emami A. The status of self-control and its relation to drug abuse related behaviours among Iranian male high school students. Social Behavior and Personality 2006; 34(4):413-24.
  10. Soltani MK, Mohammadi Z, Nasab AZ, Golfeshan F. The incidence of cleft lip and palate in a Kurd population: a prospective study. Community Dent Health 2014; 31(1):50-52.
  11. Valizadeh N, Mehdioghli R, Behroozian R. Etiologic and epidemiologic study of hepatocellular carcinoma in West Azarbaijan of Iran (2006-2011). Indian J Med Paediatr Oncol 2012; 33(4):221-3.
  12. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012; 65(9):934-9.
  13. Alireza Ayatollahi S, Mohammadpoorasl A, Rajaeifard A. Predicting the stages of smoking acquisition in the male students of Shiraz's high schools, 2003. Nicotine Tob Res 2005; 7(6):845-51.
  14. Baheiraei A, Hamzehgardeshi Z, Mohammadi MR, Nedjat S, Mohammadi E. Alcohol and drug use prevalence and factors associated with the experience of alcohol use in Iranian adolescents. Iran Red Crescent Med J 2013; 15(3):212-7.
  15. Sajjadi SS, Sajjadi SH. A study on prevalence of drug usage among teenagers in the Lamerd and Mohr cities. Asian Journal of Medical and Pharmaceutical Researches 2012; 2(1):1-4.
  16. Mohammadkhani SH. Prevalence of cigarette smoking, alcohol drinking and illegal drugs use among Iranian adolescents. Journal of Kerman University of Medical Sciences 2012; 19(1):32-48. [In Persian].
  17. Mohammadi MR, Mohammad K, Farahani FK, Alikhani S, Zare M, Tehrani FR, et al. Reproductive knowledge, attitudes and behavior among adolescent males in Tehran, Iran. Int Fam Plan Perspect 2006; 32(1):35-44.
  18. Mohammad Poorasl A, Vahidi R, Fakhari A, Rostami F, Dastghiri S. Substance abuse in Iranian high school students. Addict Behav 2007; 32(3):622-7.
  19. Mohammadpoorasl A, Fakhari A, Rostami F, Vahidi R. Predicting the initiation of substance abuse in Iranian adolescents. Addict Behav 2007; 32(12):3153-9.
  20. Najafi K, Zarrabi H, Shirazi M, Fekri F, Mohseni R. Prevalence of substance use among Iranian high school students in 2005-2006. Kuwait Medical Journal 2009; 41(1):20-5.
  21. Nazarzadeh M, Bidel Z, Carson KV. The association between tramadol hydrochloride misuse and other substances use in an adolescent population: Phase I of a prospective survey. Addict Behav 2014; 39(1):333-7.
  22. Mohammadpooras A, Fakhari A, Rostami F, Vahidi R, Dastgiri S. Epidemiologic survey of the illicit drugs and alcohol use in sophomore male students of Tabriz’s high schools. Journal of Ardabil University of Medical Sciences 2007; 7(4):400-8. [In Persian].
  23. Najafi K, Avakh F, Khalkhali MR, Nazifi F, Farahi H, Faghirpoor M. The prevalence of substance use among high-school students in Rasht city (Iran). Iranian Journal of Psychiatry and Clinical Psychology 2005; 11(2):233-36. [In Persian].
  24. Ahmadi J, Maharlooy N, Alishahi M. Substance abuse: prevalence in a sample of nursing students. J Clin Nurs 2004; 13(1):60-4.
  25. Ahmadi J, Rayisi T, Alishahi M. Analysis of substance use by primary school students. The German Journal of Psychiatry 2003; 6(3):56-9.
  26. Nakhaee N, Ziaaddini H, Karimzadeh A. Epidemiologic study on drug abuse among first and second grade high school students in Kerman. Addict Health 2009; 1(1):31-6.
  27. Ahmadi J, Yazdanfar F. Current substance abuse among Iranian university students. Addict Disord Their Treat 2002;1(2):61-4.
  28. Mohamadi N, Shobeiri F, Mahgoob H. The prevalence of substance abuse in students of Hamadan University of Medical Sciences. Zahedan Journal of Research in Medical Sciences 2012; 14(1):86-9. [In Persian].
  29. Zarrabi H, Najafi K, Kafi M, Shirazi M. Substance use among students of Guilan University of Medical Sciences in Iran in 2005-2006. Acta Medica Iranica 2009; 47(6):473-8.
  30. Shams Alizadeh N, Moghadam M, Mohsenpour B, Rostami Gooran N. Prevalence of substance abuse in medical students of Kurdistan University. Scientific Journal of Kurdistan University of Medical Sciences 2008; 13(2):18-26. [In Persian].
  31. Dehghani K, Zare A, Dehghani H, Sedghi H, Pourmovahed Z. Drug abuse prevalence and risk factors in students of Shaeed Sadoughi University of Medical Sciences, Yazd. Journal of Shahid Sadoughi University of Medical sciences 2010; 18(3):164-9. [In Persian].
  32. Mortazavi Moghadam GR, Madarshahian F, Tabiei S, Pejmankhah S, Sadeghi M. Prevalence of drug abuse among the student of Birjand Universities (2003). Modern Care J 2009; 06(1):1-4.
  33. Ashrafi Hafez A, Fakorziba MR, Babaei Heydarabadi A, Hoseyni F, Razmposh A, Gharlipour Z, et al. Assessment of psychoactive substances use and their associated factors among students of Shiraz University and Shiraz University of Medical Sciences. Journal of Ilam University of Medical Sciences 2013; 21(4):58-66. [In Persian].
  34. Shafiie N, Shamsi A, Ghaderi M. Correlation between drug use, alcohol, smoking and psychiatric drugs with the academic progress in university students in Bam city. Journal of Health Promotion Management 2013; 2(1):49-58. [In Persian].
  35. Fani A, Fani I, Eshrati B, Samadian P, Fani P, Gorishi Y, et al. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B and C in markazi province, Iran. Hepat Mon 2007; 7(3):149-52.
  36. Saedi B, Razmpa E, Ghalandarabadi M, Ghadimi H, Saghafi F, Naseri M. Epidemiology of oral cavity cancers in a country located in the esophageal cancaaer belt: a case control study. Iran J Otorhinolaryngol 2012; 24(68):113-8.
  37. Attar H, Afkham Ebrahimi A, Nasr Esfahani M. Alcohol use in hospitalized patients at Hazrat-e-Rasoul Hospital. Iranian Journal of Psychiatry & Clinical Psychology 2004; 10(1):122-9. [In Persian].
  38. Akhoond MR, Kazemnejad A, Hajizadeh E, Ghanbari Motlagh A. Comparison of colon and rectum cancer: survival and prognostic factors. Gastroenterol Hepatol Bed Bench 2010;3(4):177-86.
  39. Sayad B, Shams Aldin Saeid F, Keyvani H, Rezaei M, Asadi T, Vaziri S, et al. Seroepidemiology of hepatitis C in Kermanshah (West of Iran, 2006). Hepatitis Monthly 2008; 8(2):141-6.
  40. Saberi-Firoozi M, Khademolhosseini F, Yousefi M, Mehrabani D, Zare N, Heydari ST. Risk factors of gastroesophageal reflux disease in Shiraz, southern Iran. World J Gastroenterol 2007; 13(41):5486-91.
  41. Hajian K, Kashifard M, Davoodi H, Abedi M. Epidemiologic study of patients with oesophageal cancer referring to the Babolsar Shahid Rajaii Radiotherapy Center. J Gorgan Univ Med Sci 2003; 5(1):73-9. [In Persian].
  42. Soroush A, Makarem J, Younesian M, Fazeli M, Haji Abdolbaghi M, Noori M, et al. Wound infectious and its determinants among patients undergone general operations. Journal of Medical Council of Iran 2007; 25(4):464-73. [In Persian].
  43. Ahmadi J, Sharifi M. Prevalence of alcohol use disorders in Shiraz, Iran. J Subst Use 2002; 7(4):251-4.
  44. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 2006; 6:158.
  45. Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, et al. Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer 2005; 92(1):176-81.
  46. 46. Ahmadi J, Arabi H, Mansouri Y. Substance use in first degree relatives of opioid addicts. J Subst Use. 2001; 6(3):199-201.
  47. Kiani M, Bazmi S, Rezvani S, Naeeji H. A survey on spousal abuse of 500 victims in Iran. Am J Forensic Med Pathol 2014; 35(1):50-4.
  48. World Health Organizati (WHO). Global Information System on Alcohol and Health (GISAH): Patterns of consumption. [cited 2015 Jun 5]. Available from: http://www.who.int/gho/alcohol/consumption_patterns/en/.
  49. Bernard HR, Hallett T, Iovita A, Johnsen EC, Lyerla R, McCarty C, et al. Counting hard-to-count populations: the network scale-up method for public health. Sex Transm Infect 2010: 86(Suppl 2):ii11-5.
  50. Sheikhzadeh K, Baneshi MR, Afshari M, Haghdoost AA. Comparing direct, network scale-up, and proxy respondent methods in estimating risky behaviors among collegians. J Subst Use 2014; 21(1):1-5.
  51. Shamsipour M, Yunesian M, Fotouhi A, Jann B, Rahimi-Movaghar A, Asghari F, et al. Estimating the prevalence of illicit drug use among students using the crosswise model. Subst Use Misuse 2014; 49(10):1303-10.
  52. Mohebbi E, Baneshi MR, Haji-Maghsoodi S, Haghdoost AA. The application of network scale up method on estimating the prevalence of some disabilities in the Southeast of Iran. J Res Health Sci 2014; 14(4):272-5.
  53. Haghdoost AA, Baneshi MR, Eybpoosh S, Khajehkazemi R. Comparison of Three Interview Methods on Response Pattern to Sensitive and Non-Sensitive Questions. Iran Red Crescent Med J 2013; 15(6):500-6.
  54. Aquilino WS. Interview mode effects in surveys of drug and alcohol use: a field experiment. Public Opin Q 1994; 58(2):210-40.
  55. Sheikh K, Mattingly S. Investigating non-response bias in mail surveys. J Epidemiol Community Health 1981; 35(4):293-6.
  56. Farahani-Khalajabadi F. Methodological considerations in studying sexual behaviors of young people in Iran. J Reprod Infertil 2014; 15(4):171-2.